Mary Courtney Moore
Dept. of Molecular Physiology & Biophysics
Vanderbilt Univ. School of Medicine
702 Light Hall
Nashville
USA
Name/email consistency: high
- Diet-induced impaired glucose tolerance and gestational diabetes in the dog. Moore, M.C., Menon, R., Coate, K.C., Gannon, M., Smith, M.S., Farmer, B., Williams, P.E. J. Appl. Physiol. (2011)
- Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake. Moore, M.C., Dicostanzo, C.A., Smith, M.S., Farmer, B., Rodewald, T.D., Neal, D.W., Williams, P.E., Cherrington, A.D. Am. J. Physiol. Endocrinol. Metab. (2008)
- Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity. Moore, M.C. Curr. Opin. Investig. Drugs (2006)
- Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs. Moore, M.C., DiCostanzo, C.A., Dardevet, D., Lautz, M., Farmer, B., Cherrington, A.D. Am. J. Physiol. Endocrinol. Metab. (2005)
- Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs. Moore, M.C., Kimura, K., Shibata, H., Honjoh, T., Saito, M., Everett, C.A., Smith, M.S., Cherrington, A.D. Am. J. Physiol. Endocrinol. Metab. (2005)
- Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion. Moore, M.C., Cardin, S., Edgerton, D.S., Farmer, B., Neal, D.W., Lautz, M., Cherrington, A.D. Am. J. Physiol. Endocrinol. Metab. (2004)
- Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs. Moore, M.C., DiCostanzo, C.A., Dardevet, D., Lautz, M., Farmer, B., Neal, D.W., Cherrington, A.D. Am. J. Physiol. Endocrinol. Metab. (2004)
- Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery. Moore, M.C., Burish, M.J., Farmer, B., Neal, D.W., Pan, C., Cherrington, A.D. Am. J. Physiol. Endocrinol. Metab. (2003)